Cargando…
Trials stopped early for benefit? Not so fast!
Autores principales: | Heffner, Alan C, Milbrandt, Eric B, Venkataraman, Ramesh |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151876/ https://www.ncbi.nlm.nih.gov/pubmed/17338836 http://dx.doi.org/10.1186/cc5676 |
Ejemplares similares
-
Are specialized ICUs so special?
por: Nguyen, Yên-Lan C, et al.
Publicado: (2009) -
Albumin and furosemide for acute lung injury
por: Khan, Asjad, et al.
Publicado: (2007) -
Intensive insulin therapy in the medical ICU – not so sweet?
por: Yamada, Kyoko, et al.
Publicado: (2007) -
Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels
por: Rondon, Eliseo, et al.
Publicado: (2005) -
Steroids in early ARDS?
por: Aldabbagh, Tarek, et al.
Publicado: (2007)